Peter Radovich - Net Worth and Insider Trading

Peter Radovich Net Worth

The estimated net worth of Peter Radovich is at least $2 Million dollars as of 2024-12-27. Peter Radovich is the PRESIDENT AND COO of Mirum Pharmaceuticals Inc and owns about 29,013 shares of Mirum Pharmaceuticals Inc (MIRM) stock worth over $1 Million. Peter Radovich is also the See Remarks of Global Blood Therapeutics Inc and owns about 6,817 shares of Global Blood Therapeutics Inc (GBT) stock worth over $466,896. Details can be seen in Peter Radovich's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter Radovich has not made any transactions after 2024-03-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Peter Radovich

To

Peter Radovich Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter Radovich owns 3 companies in total, including Mirum Pharmaceuticals Inc (MIRM) , Global Blood Therapeutics Inc (GBT) , and Rain Oncology Inc (RAIN) .

Click here to see the complete history of Peter Radovich’s form 4 insider trades.

Insider Ownership Summary of Peter Radovich

Ticker Comapny Transaction Date Type of Owner
MIRM Mirum Pharmaceuticals Inc 2024-03-25 Chief Operating Officer
GBT Global Blood Therapeutics Inc 2018-02-01 See Remarks
RAIN Rain Oncology Inc 2021-04-22 director

Peter Radovich Latest Holdings Summary

Peter Radovich currently owns a total of 2 stocks. Among these stocks, Peter Radovich owns 29,013 shares of Mirum Pharmaceuticals Inc (MIRM) as of March 25, 2024, with a value of $1 Million and a weighting of 72.31%. Peter Radovich also owns 6,817 shares of Global Blood Therapeutics Inc (GBT) as of February 1, 2018, with a value of $466,896 and a weighting of 27.69%.

Latest Holdings of Peter Radovich

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MIRM Mirum Pharmaceuticals Inc 2024-03-25 29,013 42.03 1,219,416
GBT Global Blood Therapeutics Inc 2018-02-01 6,817 68.49 466,896

Holding Weightings of Peter Radovich


Peter Radovich Form 4 Trading Tracker

According to the SEC Form 4 filings, Peter Radovich has made a total of 6 transactions in Mirum Pharmaceuticals Inc (MIRM) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Mirum Pharmaceuticals Inc is the sale of 4,303 shares on March 25, 2024, which brought Peter Radovich around $111,017.

According to the SEC Form 4 filings, Peter Radovich has made a total of 0 transactions in Global Blood Therapeutics Inc (GBT) over the past 5 years. The most-recent trade in Global Blood Therapeutics Inc is the sale of 812 shares on February 1, 2018, which brought Peter Radovich around $46,528.

Insider Trading History of Peter Radovich

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Peter Radovich Trading Performance

GuruFocus tracks the stock performance after each of Peter Radovich's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter Radovich is -12.39%. GuruFocus also compares Peter Radovich's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter Radovich within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Peter Radovich's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Peter Radovich

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -2.47 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 2.87 LIMIT LIMIT LIMIT LIMIT LIMIT

Peter Radovich Ownership Network

Ownership Network List of Peter Radovich

No Data

Ownership Network Relation of Peter Radovich

Insider Network Chart

Peter Radovich Owned Company Details

What does Mirum Pharmaceuticals Inc do?

Who are the key executives at Mirum Pharmaceuticals Inc?

Peter Radovich is the Chief Operating Officer of Mirum Pharmaceuticals Inc. Other key executives at Mirum Pharmaceuticals Inc include SVP & Global Controller Jolanda Howe , director & 10 percent owner Patrick J Heron , and Chief Scientific Officer Pamela Vig .

Mirum Pharmaceuticals Inc (MIRM) Insider Trades Summary

Over the past 18 months, Peter Radovich made 4 insider transaction in Mirum Pharmaceuticals Inc (MIRM) with a net sale of 8,926. Other recent insider transactions involving Mirum Pharmaceuticals Inc (MIRM) include a net sale of 11,012 shares made by Jolanda Howe , a net purchase of 162,308 shares made by Patrick J Heron , and a net sale of 34,606 shares made by Pamela Vig .

In summary, during the past 3 months, insiders sold 2,500 shares of Mirum Pharmaceuticals Inc (MIRM) in total and bought 0 shares, with a net sale of 2,500 shares. During the past 18 months, 93,742 shares of Mirum Pharmaceuticals Inc (MIRM) were sold and 176,308 shares were bought by its insiders, resulting in a net purchase of 82,566 shares.

Mirum Pharmaceuticals Inc (MIRM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Mirum Pharmaceuticals Inc Insider Transactions

No Available Data

Peter Radovich Mailing Address

Above is the net worth, insider trading, and ownership report for Peter Radovich. You might contact Peter Radovich via mailing address: C/o Global Blood Therapeutics, Inc., 400 East Jamie Court, Suite 101, South San Francisco Ca 94080.

Discussions on Peter Radovich

No discussions yet.